Skip to main content

Publications

The following list of papers shows the range of research carried out by users of the Bio Screening Facility

Acknowledging the Facility

If you've used our Facility, please recognise and acknowledge it in your publications and grant applications. Although you pay to use the Facility, the full cost of any scientific core facility is not passed on to the end user.

The Faculty of Medical Sciences look at the quantity and quality of publications from the University research themes containing data with direct links to the BioScreening usage. This is used as a metric of facility performance (alongside the number of usage hours and cost recovery).

Acknowledging the BioScreening Facility in your papers, posters and talks will help to ensure we continue to receive faculty subsidy and continue to offer excellent access rates.

Using data generated within the BioScreening Facility

In a publication that includes data (main figures or supplemental) generated within the BioScreening Facility, please state:

“We acknowledge the Newcastle University BioScreening Facility for assistance with the generation of data”.

Working closely with BioScreening staff members

If a member of the BioScreening team has worked closely with you on a project, you should acknowledge this.

It is good practice to include their name in the acknowledgement section at least.

In situations where they have made substantial intellectual input, you can offer them a co-authorship. This should be discussed at the earliest opportunity.

 

We'd like to thank all those who have taken the trouble to recognise the efforts of this unit in supporting their research. If you have a paper published, please let us know so we can include it in this list.

Published in 2026
  • Islam, I., Wilson, J., Clegg, A., Hancock, H., Martin-Ruiz, C., McDonald, C., Sayer, A., Steves, C., von Zglinicki, T. and Witham, M. (2026) '3778 Effects of metformin on biomarkers in older people with sarcopenia: analysis from the MET-PREVENT randomised controlled trial', Age and Ageing, 55(Sup).
Published in 2025
  • Mlakar, V., Di Forti, M., Halff, E. F., Srivastava, D. P., Akkouh, I., Djurovic, S., Martin-Ruiz, C., Quintana, D. S., Birkenæs, V. and Steen, N. E. (2025) 'Coffee intake is associated with telomere length in severe mental disorders', BMJ Mental Health, 28(1).
  • Perri, G., French, C., Agostinis-Sobrinho, C., Anand, A., Antarianto, R. D., Arai, Y., Baur, J. A., Cauli, O., Clivaz-Duc, M. and Colloca, G. (2025) 'An expert consensus statement on biomarkers of aging for use in intervention studies', The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 80(5), pp. glae297.
  • Spray, L., Mcintosh, A., Mccartney, P., Martin-Ruiz, C., White, S., Berry, C. and Spyridopoulos, I. (2025) 'Cigarette smoking and release of the inflammatory chemokine CXCL10 (IP-10) after ST-elevation myocardial infarction', European Heart Journal, 46(Supplement_1), pp. ehaf784. 1890.
  • Mlakar, V., Di Forti, M., Halff, E., Srivastava, D., Djurovic, S., Martin-Ruiz, C., Quintana, D., Birkenæs, V., Steen, N. E. and Ormerod, M. (2025) 'Health behaviours and telomere length in severe mental disorders'.
Published in 2024
  • Camacho-Encina, M., Booth, L. K., Redgrave, R., Honkanen-Scott, M., Scott III, W. E., Martin-Ruiz, C., MacGowan, G., Richardson, S., Dark, J. and Tual-Chalot, S. (2024) 'Identifying optimal reference genes for real-time quantitative polymerase chain reaction in human myocardial tissues', Cardiovascular Research, 120(17), pp. 2163–2165.
  • Dirjayanto, V. J., Martin-Ruiz, C., Pompei, G., Rubino, F. and Kunadian, V. (2024) 'The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome', International Journal of Cardiology, 409, pp. 132177.
  • Perri, G., Mathers, J., Martin-Ruiz, C., Parker, C., Demircan, K., Chillon, T., Schomburg, L., Robinson, L., Stevenson, E. and Terrera, G. (2024a) 'The association between selenium status and cognitive decline in very old adults: The Newcastle 85+ Study', Proceedings of the Nutrition Society, 83(OCE2), pp. E200.
  • Perri, G., Mathers, J. C., Martin-Ruiz, C., Parker, C., Demircan, K., Chillon, T. S., Schomburg, L., Robinson, L., Stevenson, E. J. and Shannon, O. M. (2024b) 'The association between selenium status and global and attention-specific cognition in very old adults in the Newcastle 85+ Study: Cross-sectional and longitudinal analyses', The American Journal of Clinical Nutrition, 120(5), pp. 1019–1028.
Published in 2023
  • Taylor R, Barnes AC, Hollingsworth KG, Irvine KM, Solovyova AS, Clark L, et al. Aetiology of Type 2 diabetes in people with a 'normal' body mass index: testing the personal fat threshold hypothesis. Clin Sci (Lond). 2023;137(16):1333-46.
  • Perri G, Mathers JC, Martin-Ruiz C, Walsh JS, Eastell R, Schomburg L, et al. Selenium status in very old adults: Insights from the Newcastle 85+Study. P Nutr Soc. 2023;82(Oce3).
  • Perri G, Mathers JC, Martin-Ruiz C, Parker C, Walsh JS, Eastell R, et al. Selenium status and its determinants in very old adults: insights from the Newcastle 85+ Study. Br J Nutr. 2023:1-10.
  • Mlakar V, Birkenaes V, Elvsaashagen T, Ormerod M, Quintana DS, Ueland T, et al. Telomere length and verbal learning in bipolar disorders. J Affect Disord. 2023;339:555-60.
  • Booth L, Redgrave R, Camacho Encina M, Tual-Chalot S, Folaranmi O, Martin-Ruiz C, et al. The senescence-associated secretory phenotype as
Published in 2022
  • Wright JR, Deen QFE, Stevenson A, Telford-Cooke LL, Parker C, Martin-Ruiz C, et al. Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease. J Alzheimers Dis. 2022;89(4):1483-92.
  • Tinlin-Mackenzie A, Ellis CD, Lodola A, Martin-Ruiz C, Stevens JR, Fitzsimmons C. New kid on the block: first record of juvenile American lobster, H. Milne Edwards, 1837, in European waters. Bioinvasions Rec. 2022;11(4):991-1000.
  • Taylor R, Barnes AC, Irvine KM, Clark L, Al-Mrabeh A, Solovyova A, et al. Diabetes remission by weight loss in 'normal' weight people with type 2 diabetes: the ReTUNE study. Diabetologia. 2022;65(Suppl 1):S135-S.
  • Hoffmann J, Tabata N, Mas-Peiro S, Spyridopoulos I, Sinning JM, Berkowitsch A, et al. Longer leukocyte telomere length is associated with myeloid inflammation and increased mortality after transcatheter aortic valve replacement. Eur Heart J Open. 2022;2(4):oeac045.
  • Granic A, Martin-Ruiz C, Rimmer L, Dodds RM, Robinson LA, Spyridopoulos I, et al. Immunosenescence profiles of lymphocyte compartments and multiple long-term conditions (multimorbidity) in very old adults: The Newcastle 85+ Study. Mech Ageing Dev. 2022;208:111739.
  • Granic A, Martin-Ruiz C, Rimmer L, Dodds RM, Robinson L, Spyridopoulos I, et al. Immunosenescence Profiles and Multiple Long-Term Conditions in Very Old Adults: The Newcastle 85+Study. Age and Ageing. 2022;51(Suppl 2).
  • Donaghy PC, Cockell SJ, Martin-Ruiz C, Coxhead J, Kane J, Erskine D, et al. Blood mRNA Expression in Alzheimer's Disease and Dementia With Lewy Bodies. Am J Geriatr Psychiatry. 2022;30(9):964-75.
  • Amin HA, Cordell HJ, Martin-Ruiz C, Robinson L, Kirkwood T, Blakemore AI, et al. No Evidence That Genetic Variation at the Klotho Locus Is Associated With Longevity in Caucasians from the Newcastle 85+ Study and the UK Biobank. J Gerontol A Biol Sci Med Sci. 2022;77(3):457-61.
Published in 2021
Published in 2020
Published in 2019
Published in 2018
Published in 2017
Published in 2016
Published in 2015
Published in 2014